Chayab, Lara http://orcid.org/0000-0002-1196-3545
Konstantelos, Natalia
Leighl, Natasha B.
Tadrous, Mina
Wong, William W. L.
Article History
Accepted: 2 May 2023
First Online: 3 June 2023
Declarations
:
: LC is an employee of Hoffmann La-Roche, a pharmaceutical and diagnostics company. This systematic review is being conducted independent of LC’s place of employment. MT received consulting fees from CADTH and Green Shield Canada. NBL has received institutional grant funding from Amgen, Array, AstraZeneca, Bayer, BMS, Eli Lilly, EMD Serono, Guardant Health, Inivata, MSD, Novartis, Pfizer, Roche, and Takeda as well as honoraria for independent CME lectures from Amgen, BMS, EMD Serono, MSD, Novartis, Sanofi Genzyme, and Takeda.
: Author 1: Lara Chayab: Conceived and designed the systematic review protocol (objective, research question, PICO, inclusion/exclusion criteria, and methodology); Conducted the systematic review including the search strategy, study selection, assessment of methodological quality, data extraction, analysis, synthesis, and presentation; Drafted the manuscript and revised manuscript on the basis of editor and reviewer comments; Approver of the final manuscript version to be published; Accountable to all aspects of the systematic review conduct and reporting. Author 2: Natalia Konstantelos: Provided substantial intellectual contribution to the systematic review methodology design and conduct; Conducted the systematic review alongside author 1 in the capacity of independent reviewer, including study selection, assessment of methodological quality, and data extraction; Provided critical revisions to the results section of the manuscript including data analysis and presentation as well as to the full manuscript, ensuring overall accuracy, consistency, and rigor; Assisted in addressing reviewer comments and helped revise manuscript prior to resubmission; Approver of the final manuscript version to be published; Accountable to all aspects of the systematic review conduct and reporting. Author 3: Natasha B. Leighl: Provided substantial intellectual contribution to the conception and design of the systematic review objective, research question, PICO, and inclusion/exclusion criteria from a clinical (medical oncologist) expert perspective; Provided critical revisions to the background, result interpretation, discussion, and relevance/conclusion of the manuscript; Assisted in addressing reviewer comments and provided input to revised manuscript prior to resubmission; Approver of the final manuscript version to be published; Accountable to all aspects of the systematic review conduct and reporting. Author 4: Mina Tadrous: Provided substantial intellectual contribution to the conception and design of the systematic review protocol (objective, research question, PICO, inclusion/exclusion criteria, and methodology) from a health services and outcomes research expert perspective; Provided critical revisions to the results’ presentation and interpretation, to the discussion, and to the conclusion sections of the manuscript, as well as to the full manuscript, ensuring overall accuracy, consistency, and rigor; Assisted in addressing reviewer comments and provided input to revised manuscript prior to resubmission; Approver of the final manuscript version to be published; Accountable to all aspects of the systematic review conduct and reporting. Author 5: In supervision, William W.L. Wong: Provided co-leadership (and oversight to) the conception and design of the systematic review protocol and study conduct together with author 1; Conducted the systematic review alongside author 1 and author 2 in the capacity of third reviewer, which required oversight of the study selection, assessment of methodological quality, and data extraction processes; Provided critical and intellectual revisions to the full manuscript, ensuring relevance, rigor, and integrity throughout with special focus on the abstract, methodology description, the results’ analysis, presentation, and interpretation, and the key points for decision makers; Assisted in addressing reviewer comments and helped revise manuscript prior to resubmission; Approver of the final manuscript version to be published; Accountable to all aspects of the systematic review conduct and reporting.
: The team received no external funding for this study.
: The systematic review protocol is available in the International Prospective Register of systematic review, PROSPERO, under registration code CRD42022308680; ExternalRef removed. Results of the search strategy are included in this published article (and its supplementary information files).
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.